NPTH — NeuPath Health Share Price
Last trade - 00:00- CA$9.57m
- CA$18.30m
- CA$66.10m
- 62
- 96
- 76
- 92
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.43 | ||
| Price to Tang. Book | 15.21 | ||
| Price to Free Cashflow | 3.57 | ||
| Price to Sales | 0.14 | ||
| EV to EBITDA | 6.49 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -2.18% | ||
| Return on Equity | -0.49% | ||
| Operating Margin | -1.08% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 49.64 | 47.64 | 60.86 | 62.65 | 66.1 | n/a | n/a | 10.48% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
NeuPath Health Inc. operates a network of healthcare clinics and related businesses focused on improved access to care and outcomes for patients by leveraging treatments and delivering patient-centered multidisciplinary care. The Company operates a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. It provides workplace health services and independent medical assessments to employers and disability insurers through a national network of healthcare providers, as well as contract research services to pharmaceutical and biotechnology companies. The Company's health care providers cover a range of specialties, which include physiatrists, neurologists, anesthesiologists, general practitioners with specialized training in chronic pain, as well as medication management physicians, athletic therapists, and nurses.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 17th, 2019
- Public Since
- December 3rd, 2019
- No. of Employees
- 156
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 56,293,000
- Address
- 9-6400 Millcreek Drive, MISSISSAUGA, L5N 3E7
- Web
- https://www.neupath.com/
- Phone
- +1 6479639319
- Auditors
- Ernst & Young LLP
Latest News for NPTH
Upcoming Events for NPTH
NeuPath Health Inc at Bloom Burton Healthcare Investor Conference
Q1 2024 NeuPath Health Inc Earnings Release
NeuPath Health Inc Annual Shareholders Meeting
NeuPath Health Inc Extraordinary Shareholders Meeting
NeuPath Health Inc Annual Shareholders Meeting
Q2 2024 NeuPath Health Inc Earnings Release
Similar to NPTH
ARCpoint
TSX Venture Exchange
Cannara Biotech
TSX Venture Exchange
Element Lifestyle Retirement
TSX Venture Exchange
Hempshire
TSX Venture Exchange
Jack Nathan Medical
TSX Venture Exchange
FAQ
As of Today at 19:15 UTC, shares in NeuPath Health are trading at CA$0.17. This share price information is delayed by 15 minutes.
Shares in NeuPath Health last closed at CA$0.17 and the price had moved by +112.5% over the past 365 days. In terms of relative price strength the NeuPath Health share price has outperformed the Toronto Stock Exchange 300 Composite Index by +99.69% over the past year.
The overall consensus recommendation for NeuPath Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
NeuPath Health does not currently pay a dividend.
NeuPath Health does not currently pay a dividend.
NeuPath Health does not currently pay a dividend.
To buy shares in NeuPath Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.17, shares in NeuPath Health had a market capitalisation of CA$9.57m.
Here are the trading details for NeuPath Health:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: NPTH
Based on an overall assessment of its quality, value and momentum NeuPath Health is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in NeuPath Health is CA$0.50. That is 194.12% above the last closing price of CA$0.17.
Analysts covering NeuPath Health currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like NeuPath Health. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +5.04%.
As of the last closing price of CA$0.17, shares in NeuPath Health were trading +6.95% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The NeuPath Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.17.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on NeuPath Health's directors